We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jose McFaline-Figueroa

Jose McFaline-Figueroa MD, PhD

Physician, Center for Neuro-Oncology, Dana-Faber Cancer Institute; Instructor in Neurology, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Jose “Ricky” McFaline-Figueroa, MD, PhD is a physician at the Center for Neuro-Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, and an Instructor in Neurology at Harvard Medical School in Boston, MA. He received his BS in Chemistry from the University of Puerto Rico at Mayaguez, PR, and his MD and PhD at Columbia University, New York, NY. He completed his internship in internal medicine at Massachusetts General Hospital and his residency at the Harvard BWH-MGH Neurology Residency Program at Brigham and Women’s Hospital and Massachusetts General Hospital, Boston, MA. He completed his fellowship in the combined Massachusetts General Hospital/Dana-Farber Cancer Institute Neuro-Oncology Fellowship Program.

Dr. McFaline-Figueroa’s research focuses on glioblastoma, in particular, the use of combinatorial therapies to enhance response to immunotherapy in this disease. He is a recipient of the Paul Calabresi Career Development Award for Clinical Oncology and a scholar of the Massachusetts General Hospital Training Program in Central Nervous System Tumors.